MEDP — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

6.14

Margin Of Safety %

-11

Put/Call OI Ratio

1.36

EPS Next Q Diff

-0.57

EPS Last/This Y

1.74

EPS This/Next Y

1.82

Price

508.98

Target Price

515.64

Analyst Recom

2.73

Performance Q

-13.34

Upside

-33.9%

Beta

1.41

Ticker: MEDP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	MEDP	478.73	1.85	0.13	2029
2026-03-10	MEDP	466.9	1.85	0.12	2023
2026-03-11	MEDP	477.63	1.81	2.14	2035
2026-03-12	MEDP	443.38	1.82	0.50	2045
2026-03-13	MEDP	443.85	1.82	1.09	2045
2026-03-17	MEDP	454.86	1.88	0.25	2138
2026-03-18	MEDP	454.39	1.87	999.99	2139
2026-03-19	MEDP	460.64	1.86	0.22	2133
2026-03-20	MEDP	452.56	1.84	1.23	2137
2026-03-23	MEDP	456.41	1.45	0.25	856
2026-03-24	MEDP	461.67	1.40	1.43	873
2026-03-25	MEDP	466.98	1.38	8.40	876
2026-03-26	MEDP	466.59	1.41	0.67	901
2026-03-27	MEDP	451.02	1.41	2.19	906
2026-03-30	MEDP	460.24	1.43	0.00	903
2026-03-31	MEDP	480.21	1.44	0.00	899
2026-04-01	MEDP	489.02	1.42	0.56	905
2026-04-02	MEDP	498.55	1.39	0.17	948
2026-04-06	MEDP	496.29	1.38	0.90	951
2026-04-07	MEDP	508.58	1.36	0.43	966
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	MEDP	478.25	9.1	55.9	17.37
2026-03-10	MEDP	467.14	9.2	31.6	17.37
2026-03-11	MEDP	477.63	9.2	59.3	17.37
2026-03-12	MEDP	443.61	9.2	2.9	17.37
2026-03-13	MEDP	450.58	9.2	54.7	17.37
2026-03-17	MEDP	455.16	9.2	47.6	17.37
2026-03-18	MEDP	455.17	9.2	44.8	17.37
2026-03-19	MEDP	460.64	9.2	60.4	17.37
2026-03-20	MEDP	452.51	9.2	41.0	17.37
2026-03-23	MEDP	457.11	9.2	58.2	17.37
2026-03-24	MEDP	461.71	9.2	58.5	17.37
2026-03-25	MEDP	466.83	9.2	60.1	17.37
2026-03-26	MEDP	466.73	9.2	52.0	17.37
2026-03-27	MEDP	451.20	9.2	32.1	17.37
2026-03-30	MEDP	460.46	9.2	64.5	17.37
2026-03-31	MEDP	480.47	9.2	79.1	17.37
2026-04-01	MEDP	489.25	9.2	63.2	17.37
2026-04-02	MEDP	498.38	9.2	63.3	17.37
2026-04-06	MEDP	496.05	9.2	52.0	17.39
2026-04-07	MEDP	508.98	9.2	70.6	17.39
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	MEDP	-6.59	-1.82	5.65
2026-03-10	MEDP	-6.59	-1.82	5.65
2026-03-11	MEDP	-6.59	-1.82	5.63
2026-03-12	MEDP	-6.59	-1.82	5.63
2026-03-13	MEDP	-6.59	-1.82	5.63
2026-03-17	MEDP	-6.59	-1.75	5.63
2026-03-18	MEDP	-6.59	-1.75	5.63
2026-03-19	MEDP	-7.08	-1.75	5.63
2026-03-20	MEDP	-7.08	-1.75	5.63
2026-03-23	MEDP	-7.08	-1.76	5.63
2026-03-24	MEDP	-7.08	-1.76	5.63
2026-03-25	MEDP	-7.08	-1.76	6.14
2026-03-26	MEDP	-7.08	-1.76	6.14
2026-03-27	MEDP	-7.08	-1.76	6.14
2026-03-30	MEDP	-7.08	-1.76	6.14
2026-03-31	MEDP	-7.08	-1.76	6.14
2026-04-01	MEDP	-7.08	-1.76	6.14
2026-04-02	MEDP	-7.08	-1.76	6.14
2026-04-06	MEDP	-7.08	-1.71	6.14
2026-04-07	MEDP	-7.08	-1.71	6.14
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

4.67

Avg. EPS Est. Current Quarter

4.01

Avg. EPS Est. Next Quarter

4.1

Insider Transactions

-7.08

Institutional Transactions

-1.71

Beta

1.41

Average Sales Estimate Current Quarter

697

Average Sales Estimate Next Quarter

701

Fair Value

452.5

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.1

Max Drawdown 5-Year %

-42.9

Target Price

515.64

P/E

33.25

Forward P/E

26.67

PEG

2.12

P/S

5.74

P/B

31.35

P/Free Cash Flow

21.3

EPS

15.29

Average EPS Est. Cur. Y

17.39

EPS Next Y. (Est.)

19.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.83

Relative Volume

0.95

Return on Equity vs Sector %

70.8

Return on Equity vs Industry %

87.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

70.6

◆ MEDP Healthcare

$508.52

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

7/15

Valuation

8/20

TP/AR

0/10

Options

1/10

RSI

64.6

Range 1M

99.7%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

14/30

Estimates

5/20

Inst/Vol

2/15

Options

3/10

EPS Yr

12.3%

EPS NY

11.2%

52W%

68.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -11.5% upside

Quality

20/30

Valuation

2/30

Growth

13/25

Stability

4/10

LT Trend

3/5

Upside

-11.5%

Quality

MoS

-11%

Medpace Holdings, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6200

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

MEDP

Latest News

—

Caricamento notizie per MEDP…

stock quote shares MEDP – Medpace Holdings, Inc. Stock Price stock today

news today MEDP – Medpace Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MEDP – Medpace Holdings, Inc. yahoo finance google finance

stock history MEDP – Medpace Holdings, Inc. invest stock market

stock prices MEDP premarket after hours

ticker MEDP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MEDP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y